Skip to main content
. 2019 Nov 10;34(2):197–203. doi: 10.15605/jafes.034.02.11

Table 3.

PHQ score and severity of depression among patients with type 2 diabetes mellitus

Variable None to Minimal Mild Moderate to Moderately Severe p-value
Gender
 Male 153 (87.9) 12 (6.9) 9 (5.2) 0.008*
 Female
233 (77.2)
48 (15.9)
21 (6.9)
 
Marital Status
 Never married 54 (74.0) 11 (15.0) 8 (11.0) 0.142
 Married 298 (83.2) 40 (11.2) 20 (5.6)
 Widowed
34 (75.6)
9 (20.0)
2 (4.4)
 
Educational Status
 Elementary 27 (96.4) 1 (3.6) 0 (0.0) 0.072
 High School 70 (76.9) 13 (14.3) 8 (8.8)
 College/Vocational 271 (82.4) 39 (11.9) 19 (5.8)
 Post graduate
18 (64.3)
7 (25.0)
3 (10.7)
 
Employment
 Not employed 217 (83.8) 29 (11.2) 13 (5.0) 0.236
 Employed
169 (77.9)
31 (14.3)
17 (7.8)
 
BMI category
 Underweight 76 (85.4) 5 (5.6) 8 (9.0) 0.012*
 Normal 7 (58.3) 2 (16.7) 3 (25.0)
 Overweight 69 (75.8) 15 (16.5) 7 (7.7)
 Obese
234 (82.4)
38 (13.4)
12 (4.2)
 
Duration of Diabetes
 <1 year 27 (73.0) 7 (18.9) 3 (8.1) 0.509
 1-5 years 122 (78.7) 23 (14.8) 10 (6.4)
 6-10 years 92 (86.8) 10 (9.4) 4 (3.8)
 >10 years
144 (81.4)
20 (11.3)
13 (7.3)
 
DM control
 Controlled 203 (85.3) 21 (8.8) 14 (5.9) 0.035*
 Uncontrolled
142 (75.9)
31 (16.6)
14 (7.5)
 
Complications
 Retinopathy 103 (75.2) 25 (18.2) 9 (6.6) 0.058
 Nephropathy 98 (77.2) 23 (18.1) 6 (4.7) 0.075
 Neuropathy 156 (77.2) 35 (17.3) 11 (5.5) 0.026*
 Stroke 34 (80.9) 7 (16.7) 1 (2.4) 0.433
 CAD 43 (87.8) 5 (10.2) 1 (2.0) 0.447
 PAOD
24 (82.8)
3 (10.3)
2 (6.9)
1.000
Number of Medications
 0 16 (88.9) 2 (11.1) 0 (0.0) 0.678
 1-2 246 (81.2) 35 (11.5) 22 (7.3)
 3 or more
124 (80.0)
23 (14.8)
8 (52)
 
Comorbidities
 Hypertension 248 (83.8) 34 (11.5) 14 (4.7) 0.103
 Dyslipidemia 208 (84.2) 23 (9.3) 16 (6.5) 0.073
 Hyperuricemia 18 (94.7) 0 (0.0) 1 (5.3) 0.245
 Hypothyroidism
16 (80.0)
2 (10.0)
2 (10.0)
0.673
Morisky Medication Adherence
 Low 102 (66.7) 35 (22.9) 16 (10.5) 0.000*
 Medium 123 (84.8) 14 (9.7) 8 (5.5)
 High 161 (90.4) 11 (6.2) 6 (3.4)

BMI, Body Mass Index; DM, Diabetes Mellitus; CAD, Coronary Artery Disease; PAOD, Peripheral Arterial Occlusive Disease

*

Significant at 0.05 level